Clinical Trial

A Study to Evaluate ALN-4324 on Insulin Sensitivity in Adults With Type 2 Diabetes Mellitus

Name: A Study to Evaluate ALN-4324 on Insulin Sensitivity in Adults With Type 2 Diabetes Mellitus — clinical trial record (NCT07465224)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

The purpose of this study is to evaluate the effect of a single dose of ALN-4324 on whole-body insulin sensitivity in participants with T2DM

Protocol Amendment History 1 change

notable Enrollment reduced: 40 -> 24 participants 2026-07-24

Trial Details

NCT Number	NCT07465224
Lead Sponsor	Alnylam Pharmaceuticals
Conditions	Type 2 Diabetes Mellitus (T2DM)
Enrollment	24 participants
Start Date	2026-01-15
Primary Completion	2027-05-28 (estimated)
Study Completion	2027-05-28 (estimated)
Updated on ClinicalTrials.gov	2026-08-12